Sandeep Sehdev

1.0k total citations
35 papers, 451 citations indexed

About

Sandeep Sehdev is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sandeep Sehdev has authored 35 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 14 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sandeep Sehdev's work include Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Sandeep Sehdev is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Sandeep Sehdev collaborates with scholars based in Canada, United States and Spain. Sandeep Sehdev's co-authors include Sunil Verma, Tadeusz Pieńkowski, W. Eiermann, John Crown, Louise Provencher, Guido Sauter, Semiglazov Vf, Mansoor N. Saleh, Michael F. Press and Saeed Sadeghi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Sandeep Sehdev

34 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandeep Sehdev Canada 13 272 201 122 54 40 35 451
Doris Augustin Germany 11 221 0.8× 191 1.0× 82 0.7× 42 0.8× 29 0.7× 59 345
R. Wolters Germany 10 192 0.7× 187 0.9× 69 0.6× 46 0.9× 26 0.7× 14 330
Jia-Yuan Li China 7 284 1.0× 177 0.9× 56 0.5× 55 1.0× 44 1.1× 11 421
Débora S. Bruno United States 12 215 0.8× 82 0.4× 128 1.0× 51 0.9× 21 0.5× 45 352
Zhong-Hua Tang China 7 277 1.0× 182 0.9× 57 0.5× 44 0.8× 42 1.1× 9 415
Derrick S. Haslem United States 9 208 0.8× 175 0.9× 154 1.3× 54 1.0× 51 1.3× 30 459
JN Atkins United States 11 303 1.1× 143 0.7× 200 1.6× 117 2.2× 50 1.3× 22 500
Domen Ribnikar Canada 11 291 1.1× 199 1.0× 151 1.2× 97 1.8× 104 2.6× 31 470
Bao‐Ning Zhang China 8 295 1.1× 184 0.9× 58 0.5× 55 1.0× 52 1.3× 11 445
Z. Ballatore Italy 11 306 1.1× 174 0.9× 132 1.1× 94 1.7× 70 1.8× 35 544

Countries citing papers authored by Sandeep Sehdev

Since Specialization
Citations

This map shows the geographic impact of Sandeep Sehdev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandeep Sehdev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandeep Sehdev more than expected).

Fields of papers citing papers by Sandeep Sehdev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandeep Sehdev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandeep Sehdev. The network helps show where Sandeep Sehdev may publish in the future.

Co-authorship network of co-authors of Sandeep Sehdev

This figure shows the co-authorship network connecting the top 25 collaborators of Sandeep Sehdev. A scholar is included among the top collaborators of Sandeep Sehdev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandeep Sehdev. Sandeep Sehdev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
McGee, Sharon F., Mark Clemons, Gregory R. Pond, et al.. (2024). A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer. Current Oncology. 31(8). 4531–4545. 2 indexed citations
3.
Cao, Jeffrey, Jean-François Boileau, Karen A. Gelmon, et al.. (2024). Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer. Current Oncology. 31(11). 7226–7243. 2 indexed citations
4.
Stewart, David J., Sandeep Sehdev, Vishal Navani, et al.. (2024). New Anticancer Drugs: Reliably Assessing “Value” While Addressing High Prices. Current Oncology. 31(5). 2453–2480. 5 indexed citations
5.
Sehdev, Sandeep, Nigel S. B. Rawson, Marcus O. Butler, et al.. (2024). Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement. Current Oncology. 31(4). 1803–1816. 4 indexed citations
6.
Gelmon, Karen A., Jean-François Boileau, Christine Brezden‐Masley, et al.. (2024). Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting. Current Oncology. 31(11). 6536–6567. 1 indexed citations
7.
Brezden‐Masley, Christine, Anil A. Joy, Sandeep Sehdev, et al.. (2023). Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigm. Therapeutic Advances in Medical Oncology. 15. 2620176–2620176. 8 indexed citations
8.
Papp, Kim, Barbara Melosky, Sandeep Sehdev, et al.. (2023). Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel. Dermatology and Therapy. 13(4). 867–889. 10 indexed citations
9.
Rayson, Daniel, Sonal Gandhi, Anil A. Joy, et al.. (2022). Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Current Oncology. 29(12). 9891–9895. 2 indexed citations
10.
McGee, Sharon F., Carol Stober, Terry L. Ng, et al.. (2021). Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation. Journal of bone oncology. 27. 100351–100351. 3 indexed citations
11.
Clemons, Mark, Sharon F. McGee, Lisa Vandermeer, et al.. (2021). Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient survey. Supportive Care in Cancer. 29(11). 6903–6912. 6 indexed citations
12.
Sehdev, Sandeep, Jean M. Seely, Denis Gravel, et al.. (2021). Neoadjuvant Chemotherapy in Breast Cancer: Review of the Evidence and Conditions That Facilitated Its Use during the Global Pandemic. Current Oncology. 28(2). 1338–1347. 14 indexed citations
13.
Clemons, Mark, George Dranitsaris, Sandeep Sehdev, et al.. (2020). A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting. The Breast. 54. 278–285. 21 indexed citations
14.
15.
Ellis, Peter, Sunil Verma, Sandeep Sehdev, Jawaid Younus, & Natasha B. Leighl. (2013). Challenges to Implementation of an Epidermal Growth Factor Receptor Testing Strategy for Non–Small-Cell Lung Cancer in a Publicly Funded Health Care System. Journal of Thoracic Oncology. 8(9). 1136–1141. 32 indexed citations
16.
Madarnas, Yolanda, et al.. (2011). Models of Care for Early-Stage Breast Cancer in Canada. Current Oncology. 18(10). 10–19. 17 indexed citations
17.
Verma, Sunil, Yolanda Madarnas, Sandeep Sehdev, G. Martin, & Jana Bajcar. (2011). Patient Adherence to Aromatase Inhibitor Treatment in the Adjuvant Setting. Current Oncology. 18(10). 3–9. 23 indexed citations
18.
Verma, Sunil, Sandeep Sehdev, Anil A. Joy, et al.. (2009). An Updated Review on the Efficacy of Adjuvant Endocrine Therapies in Hormone Receptor–Positive Early Breast Cancer. Current Oncology. 16(11). 1–13. 2 indexed citations
19.
Sehdev, Sandeep, et al.. (2009). Safety of Adjuvant Endocrine Therapies in Hormone Receptor–Positive Early Breast Cancertissues. Current Oncology. 16(11). 14–23. 24 indexed citations
20.
Verma, Sunil, et al.. (2007). Cancer Therapy Disparity: Unequal Access to Breast Cancer Therapeutics and Drug Funding in Canada. Current Oncology. 14(11). 3–10. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Doris Augustin Breakdown of academic impact, for papers by R. Wolters Breakdown of academic impact, for papers by Jia-Yuan Li Breakdown of academic impact, for papers by Débora S. Bruno Breakdown of academic impact, for papers by Zhong-Hua Tang Breakdown of academic impact, for papers by Derrick S. Haslem Breakdown of academic impact, for papers by JN Atkins Breakdown of academic impact, for papers by Domen Ribnikar Breakdown of academic impact, for papers by Bao‐Ning Zhang Breakdown of academic impact, for papers by Z. Ballatore
Rankless by CCL
2026